US 9974742
Emulsion formulations of an NK-1 receptor antagonist and uses thereof
granted A61KA61K31/43A61K31/435
Quick answer
US patent 9974742 (Emulsion formulations of an NK-1 receptor antagonist and uses thereof) held by Heron Therapeutics, Inc. expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Heron Therapeutics, Inc.
- Grant date
- Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K31/43, A61K31/435, A61K31/496, A61K31/5377